Advances in medical, biomedical and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of clinical practice guidelines and how they can be improved to enhance healthcare quality and patient outcomes. Clinical practice guidelines now are ubiquitous in our healthcare system. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy clinical practice guidelines emphasizing transparency; management of conflict of interest ; systematic review-guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality (AHRQ), as well as various Congressional staff and policymakers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use clinical practice guidelines, consumers, clinicians, and payers.

Everything you need to pass the NAPLEX® – comprehensive study material and two practice exams – in one student-reviewed package Written by an instructor who has taught thousand of students, this all-in-one study guide was developed and reviewed by pharmacists, faculty, students, and recent graduates – so you know it contains only the most relevant, up-to-date conent. You’ll find valuable foundational material and chapter-ending case application questions that cover every key topic included on the NAPLEX. Two downloadable practice tests with a total of 370 questions allowing you to pinpoint your weaknesses. Includes: Coverage that is organized around the NABP competencies and designed to sharpen problem-solving skills, put must-know information at your fingertips, and improve exam-taking ability More than 1400 case application questions, each with a detailed explanation of both correct and incorrect answer choices Takeaway Points at the end of every chapter that summarize key concepts Two complete downloadable practice tests, each with 185 questions

In Cannabis Pharmacy, expert Michael Backes offers evidence-based information on using cannabis to treat an array of ailments and conditions. He provides information on how cannabis works with the body's own system, how best to prepare and administer it, and how to modify and control dosage. This newly revised edition is now completely up-to-date with the latest information on the body's encannabinoid system, which is now understood to control emotion, appetite, and memory, delivery and dosing of cannabis, including e-cigarette designs, additional varietals, and a new system for classification, as well as 21 additional ailments and conditions that can be treated with medical marijuana. There are currently more than 4.2 million medical cannabis patients in the United States, and there are 29 states plus the District of Columbia where medical cannabis is legal.

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. The most concise, clinically relevant, and current review of medical microbiology and immunology Review of Medical Microbiology and Immunology is a succinct, high-yield review of the medically important aspects of microbiology and immunology. It covers both the basic and clinical aspects of bacteriology, virology, mycology, parasitology, and immunology and also discusses important infectious diseases using an organ system approach. The book emphasizes the real-world clinical application of microbiology and immunology to infectious diseases and offers a unique mix of narrative text, color images, tables and figures, Q&A, and clinical vignettes. • Content is valuable to any study objective or learning style • Essential for USMLE review and medical microbiology coursework • 650 USMLE-style practice questions test your knowledge and understanding • 50 clinical cases illustrate the importance of basic science information in clinical diagnosis • A complete USMLE-style practice exam consisting of 80 questions helps you prepare for the exam • Pearls impart important basic science information helpful in answering questions on the USMLE • Concise summaries of medically important organisms • Self-assessment questions with answers appear at the end of each chapter • Color images depict clinically important findings, such as infectious disease lesions • Gram stains of bacteria, electron micrographs of viruses, and microscopic images depict fungi, protozoa, and worms • Chapters on infectious diseases from an organ system perspective

Collaborations of physicians and researchers with industry can provide valuable benefits to society, particularly in the translation of basic scientific discoveries to new therapies and products. Recent reports and news stories have, however, documented disturbing examples of relationships and practices that put at risk the integrity of medical research, the objectivity of professional education, the quality of patient care, the soundness of clinical practice guidelines, and the public's trust in medicine. Conflict of Interest in Medical Research, Education, and Practice provides a comprehensive look at conflict of interest in medicine. It offers principles to inform the design of policies to identify, limit, and manage conflicts of interest without damaging constructive collaboration with industry. It calls for both short-term actions and long-term commitments by institutions and individuals, including leaders of academic medical centers, professional societies, patient advocacy groups, government agencies, and drug, device, and pharmaceutical companies. Failure of the medical community to take convincing action on conflicts of interest invites additional legislative or regulatory measures that may be overly broad or unduly burdensome. Conflict of Interest in Medical Research, Education, and Practice makes several recommendations for strengthening conflict of interest policies and curbing relationships that create risks with little benefit. The book will serve as an invaluable resource for individuals and organizations committed to high ethical standards in all realms of medicine.

Healthcare decision makers in search of reliable information that compares health interventions increasingly turn to systematic reviews for the best summary of the evidence. Systematic reviews identify, select, assess, and synthesize the findings of similar but separate studies, and can help clarify what is known and not known about the potential benefits and harms of drugs, devices, and other healthcare services. Systematic reviews can be helpful for clinicians who want to integrate research findings into their daily practices, for patients to make well-informed choices about their own care, for professional medical societies and other organizations that develop clinical practice guidelines. Too often systematic reviews are of uncertain or poor quality. There are no universally accepted standards for developing systematic reviews leading to variability in how conflicts of interest and biases are handled, how evidence is appraised, and the overall scientific rigor of the process. In Finding What Works in Health Care the Institute of Medicine (IOM) recommends 21 standards for developing high-quality systematic reviews of comparative effectiveness research. The standards address the entire systematic review process from the initial steps of formulating the topic and building the review team to producing a detailed final report that synthesizes what the evidence shows and where knowledge gaps remain. Finding What Works in Health Care also proposes a framework for improving the quality of the science underpinning systematic reviews. This book will serve as a vital resource for both sponsors and producers of systematic reviews of comparative effectiveness research.

The complete home reference to over 2,500 medicines - fully revised and updated. The BMA New Guide to Medicine & Drugs Ninth Edition is the fully updated, quick-reference guide to drugs for anyone wanting to know more about the medication they're taking, from Britain's leading authority. Jargon-free and easy-to-follow, get all the vital information you need on 2,500 of today's prescription and over-the-counter drugs fast. Find advice on understanding and using medicines and learn how they work, what they treat, their risks, benefits, side effects, and how to use them safely and effectively. Plus, get detailed full-page profiles of 276 commonly used medicines and information about drugs new to the market. Essential guidance for anyone taking medication, or wanting to know more about the major drugs used in common medical practice. The BMA New Guide to Medicine and Drugs Ninth Edition is perfect for the family bookshelf and for healthcare professionals.

Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.